Strike Capital
San Francisco, United States2
65M
2
1.00
- Areas of investment
Investor highlights
- Industry focus
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Analytics
- Total investments
- 2
- Lead investments
- 0
- Rounds per year
- 1.00
- Investments by industry
- Software (2)
- Supply Chain Management (1)
- Warehousing (1)
- Freight Service (1)
- Logistics (1) Show 4 more
- Investments by region
- United States (2)
- Peak activity year
- 2022
- Number of Unicorns
- 1
- Number of Decacorns
- 1
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 6
- Avg. valuation at time of investment
- 600M
- Group Appearance index
- 1.00
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Triumph | 10 May 2023 | Software, Gaming, Developer Platform, Online Games | Early Stage Venture | 10M | United States, California, San Francisco |
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Nanochon , a Washington, D.C.-based orthopedic device company developing an implant for treating articular cartilage defects in the knee | Dec 1, 2026 | Biotech, Medical Device | - | 4100000 USD | D.C.-based orthopedic device company, a Washington |
| Prana Thoracic | Dec 8, 2024 | Image-guided minimally invasive surgery, Image-guided Surgery, Lung Cancer Intervention, Medical Devices, Medtech, Minimally Invasive Devices, Minimally Invasive Surgery, Personalized treatment plans, Personalized Treatment Plans | - | - | Houston, Texas |
| Prana Thoracic | Aug 8, 2024 | Image-guided minimally invasive surgery, Image-guided Surgery, Lung Cancer Intervention, Medical Devices, Medtech, Minimally Invasive Devices, Minimally Invasive Surgery, Personalized treatment plans, Personalized Treatment Plans | Early stage | 3000000 USD | Houston, Texas |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.